Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Inga Abed
Institution:
European Medicines Agency
Observed institution:
European Medicines Agency
ORCID:
0000-0003-0520-9076
Observed ORCID:
0000-0003-0520-9076
OpenAlex ID:
A5001443852
Commentary on the European Medicines Agency's extended mandate: Protecting public health in times of crisis and improving availability of medicines and medical devices
2022
·
Inga Abed
, Rosa Gonzalez‐Quevedo
, et al.
·
British Journal of Clinical Pharmacology
·
13
The approval process of medicines in Europe
2014
·
Inga Abed
·
Medical Writing
·
9
Public information on shortages in the EU/EEA: improvements made between 2018 and 2020
2023
·
Inga Abed
, Juan Garcia Burgos
, et al.
·
European Journal of Hospital Pharmacy
·
4
PDF
The impact of the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) to address shortages of human and veterinary medicines across Europe
2025
·
Inga Abed
, Vanessa Bennett
, et al.
·
Frontiers in Public Health
·
3
PDF
A regulatory perspective on the first approved EU application to reformulate an inhaled medicine with a gas propellant with reduced global warming potential
2026
·
Claudia Vincenzi
, Carina Klebl
, et al.
·
British Journal of Clinical Pharmacology
Show more works
View as search
Works count:
5
Citation count:
29
H-index:
3
I10-index:
1
Year
Topic
Type